APRE
Aprea Therapeutics, Inc. Common stock
$0.86
-4.42%
-0.04
Notify me if price changes either direction
Buy APRE stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
11.1M
Enterprise value
-3222351
Trailing PE
0.47928512
Forward PE
-1.4089394
PEG Ratio
-0.013814688752941
Enterprise to EBITDA
0.244
Enterprise to revenue
-11.276
Price to book MRQ
0.61217904
Price to sales TTM
38.993637
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2025-12-31
Revenue (TTM)
285.8K
EBITDA
-13212121
Diluted EPS TTM
-1.93
Total Cash (MRQ)
14.6M
Current ratio (MRQ)
5.629
Operating Cash Flow (TTM)
-12894439
APRE trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
April 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
